Lilly Takes Aim At Synthon Over Adcirca ANDA
Eli Lilly & Co. has filed a patent infringement suit against Synthon Pharmaceuticals Inc. over its attempt to introduce a generic version of hypertension drug Adcirca....To view the full article, register now.
Already a subscriber? Click here to view full article